Online Program Home
  My Program
CC = Baltimore Convention Center,    H = Hilton Baltimore
* = applied session       ! = JSM meeting theme

Activity Details

291 Tue, 8/1/2017, 8:30 AM - 10:20 AM CC-322
SPEED: Biopharmaceutical Statistics — Contributed Speed
Biopharmaceutical Section , Section on Statistical Learning and Data Science
Chair(s): Veronica L. Powell, QST Consultations
The Poster portion will take place during Session 214585
8:35 AM Tradeoffs of a Randomize, Then Consent Approach to Improving Cluster Participation Rates in Cluster Randomize Trials Abigail Shoben, The Ohio State University
8:40 AM Sample Size for Joint Testing Cause-Specific Hazard and Overall Hazard in the Presence of Competing Risks Qing Yang, Duke University ; Gang Li, University of California, Los Angeles
8:45 AM Accounting for Baseline Covariates and Missing Data in Regulatory Trials with Longitudinal Designs Elizabeth Colantuoni, Johns Hopkins University ; Jon Steingrimsson, Johns Hopkins University ; Aidan McDermott, Johns Hopkins University ; Michael Rosenblum, Johns Hopkins University
8:50 AM Robust Feature Selection and Cell Line Classification with Electric Cell-Substrate Impedance Sensing Data Megan Gelsinger, Cornell University ; David S Matteson, Cornell University ; Laurie Tupper, Williams College
8:55 AM Comparing Biomarker-Guided Treatment Strategies Using Local Posterior Predictive Benefit Meilin Huang, The University of Texas MD Anderson Cancer Center ; Brian P. Hobbs, The University of Texas MD Anderson Cancer Center
9:00 AM A Comparison of Assay Platforms Using Correlation Coefficients in the Presence of Repeated Measurements Qinlei Huang, Merck & Co. ; Radha Railkar, Merck & Co. ; Anita Lee, Merck & Co.
9:10 AM On Measure of Surrogacy for Biomarkers in Medical Research. Rui Zhuang, University of Washington ; Ying Qing Chen, Fred Hutchinson Cancer Research Center
9:15 AM Discriminant Analysis (DA) Based Methods in Safety Evaluation Angang Zhang, Merck ; Richard Baumgartner, Merck ; William W Wang, Merck & Co Inc
9:20 AM On the Estimation of Risk Difference in the Presence of Continuous Baseline Covariates Hua Ma, Merck ; Robin Mogg, Merck
9:30 AM Power Comparison of Tests of Restricted Mean Survival Time with Log-Rank Test and Generalized Wilcoxon Test Under Various Survival Distributions Musashi Fukuda, Astellas Pharma Inc. ; Yutaka Matsuyama, Department of Biostatistics, School of Public Health, The University of Tokyo
9:35 AM Optimal Designs for Pharmacokinetic Studies Analyzed Using Non-Compartmental Methods Helen Barnett, Lancaster University ; Thomas Jaki, Lancaster University ; Helena Geys, Janssen Pharmaceutica ; Tom Jacobs, Janssen Pharmaceutica
9:40 AM Statistical Considerations in Delayed-Start Design to Demonstrate Disease Modification Effect in Neurodegenerative Disorders Jun Zhao, AbbVie Inc. ; Deli Wang, AbbVie, Inc. ; Weining Z Robieson, AbbVie Inc.
9:45 AM Placebo-Based Multiple Imputation Methods for Sensitivity Analysis in Recurrent Event Data Rui Yang, Chiltern International Inc
9:50 AM Sample Size Calculation for the Generalized Poisson Regression Model Comparing Two Rates of Recurrent Events Kimitoshi Ikeda, Amgen Astellas BioPharma K.K.
9:55 AM Sample Size Calculation to Support Local Submission Zhuqing Yu, AbbVie ; Bidan Huang, AbbVie ; Jun Zhao, AbbVie Inc. ; lu cui, Abbvie
10:00 AM An Examination of the Association Between Alcohol and Dementia in a Longitudinal Study Tingting Hu, Florida State University ; Dan McGee, Florida State University ; Elizabeth Slate, Florida State University
10:05 AM Design and Statistical Analysis of Method Transfer Studies for Biotechnology Products Meiyu Shen, C DER, FDA ; Lixin Xu, FDA
10:15 AM Floor Discussion
Copyright © American Statistical Association